One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...

Zydus Lifesciences has partnered with Synthon BV in a deal to develop, license, supply, and commercialize a novel oncology ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

The human body is teeming with trillions of symbiotic microorganisms, profoundly impacting our well-being. Within the gut, ...

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.